StockNow
Log in
U.S. Markets

Abbott Laboratories (ABT) wins dismissal of shareholder lawsuit stemming from 2022 infant Formula recall, according to a court ruling

StockNow breaking-news AI analysis

Abbott won a dismissal of a 2022 recall-related shareholder lawsuit, reducing immediate legal pressure. However, significant risks remain from 1,700+ ongoing NEC lawsuits and a PediaSure false advertising case.

1 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
U.S. Markets

Eli Lilly (LLY) Q2 2026 (USD): Adj. EPS 8.38 (exp. 6.01), Revenue 23bln (exp. 20.7bln)

LLYGeopolitics

Pakistani sources say Pakistan PM Sharif and Army Chief Munir will visit Saudi Arabia tomorrow, Al Hadath reports

U.S. Economy

US ADP Employment Change (Jul) 44K vs. Exp. 70K (Prev. 98K)